nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—SLC7A11—forebrain—attention deficit hyperactivity disorder	0.14	0.166	CbGeAlD
Riluzole—SLC7A11—midbrain—attention deficit hyperactivity disorder	0.0925	0.109	CbGeAlD
Riluzole—SLC7A11—nervous system—attention deficit hyperactivity disorder	0.0761	0.0899	CbGeAlD
Riluzole—SLC7A11—central nervous system—attention deficit hyperactivity disorder	0.0732	0.0866	CbGeAlD
Riluzole—SLC7A11—cerebellum—attention deficit hyperactivity disorder	0.0716	0.0846	CbGeAlD
Riluzole—SCN5A—cardiovascular system—attention deficit hyperactivity disorder	0.0713	0.0843	CbGeAlD
Riluzole—SLC7A11—brain—attention deficit hyperactivity disorder	0.0581	0.0687	CbGeAlD
Riluzole—SCN5A—nervous system—attention deficit hyperactivity disorder	0.0458	0.0541	CbGeAlD
Riluzole—SCN5A—central nervous system—attention deficit hyperactivity disorder	0.0441	0.0521	CbGeAlD
Riluzole—SCN5A—brain—attention deficit hyperactivity disorder	0.035	0.0414	CbGeAlD
Riluzole—ABCG2—midbrain—attention deficit hyperactivity disorder	0.0305	0.036	CbGeAlD
Riluzole—CYP1A1—nervous system—attention deficit hyperactivity disorder	0.0238	0.0281	CbGeAlD
Riluzole—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.0236	0.0279	CbGeAlD
Riluzole—CYP1A1—central nervous system—attention deficit hyperactivity disorder	0.0229	0.0271	CbGeAlD
Riluzole—ABCG2—brain—attention deficit hyperactivity disorder	0.0191	0.0226	CbGeAlD
Riluzole—CYP1A1—brain—attention deficit hyperactivity disorder	0.0182	0.0215	CbGeAlD
Riluzole—SCN5A—Interaction between L1 and Ankyrins—ANK3—attention deficit hyperactivity disorder	0.018	0.117	CbGpPWpGaD
Riluzole—SLC7A11—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A9—attention deficit hyperactivity disorder	0.0169	0.11	CbGpPWpGaD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00757	0.0491	CbGpPWpGaD
Riluzole—SCN5A—L1CAM interactions—ANK3—attention deficit hyperactivity disorder	0.0069	0.0447	CbGpPWpGaD
Riluzole—ABCG2—Fluoropyrimidine Activity—DPYD—attention deficit hyperactivity disorder	0.00687	0.0445	CbGpPWpGaD
Riluzole—CYP1A2—Methylation—COMT—attention deficit hyperactivity disorder	0.00474	0.0308	CbGpPWpGaD
Riluzole—SLC7A11—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00469	0.0304	CbGpPWpGaD
Riluzole—CYP1A1—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00465	0.0301	CbGpPWpGaD
Riluzole—SLC7A11—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00418	0.0271	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00385	0.0249	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00367	0.0238	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.0033	0.0214	CbGpPWpGaD
Riluzole—CYP1A1—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00315	0.0204	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00314	0.0204	CbGpPWpGaD
Riluzole—CYP1A1—Oxidative Stress—MAOA—attention deficit hyperactivity disorder	0.00307	0.0199	CbGpPWpGaD
Riluzole—CYP1A2—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00296	0.0192	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00283	0.0184	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00264	0.0171	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00264	0.0171	CbGpPWpGaD
Riluzole—SLC7A11—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00263	0.0171	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00261	0.0169	CbGpPWpGaD
Riluzole—CYP1A2—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00201	0.013	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00198	0.0129	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00191	0.0124	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00186	0.0121	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00184	0.0119	CbGpPWpGaD
Riluzole—ABCG2—HIF-2-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00177	0.0115	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00168	0.0109	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.00165	0.0107	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00162	0.0105	CbGpPWpGaD
Riluzole—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00143	0.00926	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00139	0.00903	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00134	0.00868	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00133	0.00862	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00131	0.0085	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.0012	0.00777	CbGpPWpGaD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00104	0.00675	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000941	0.0061	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000941	0.0061	CbGpPWpGaD
Riluzole—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000911	0.0059	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000856	0.00555	CbGpPWpGaD
Riluzole—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.000833	0.0054	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000764	0.00495	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000759	0.00492	CbGpPWpGaD
Riluzole—CYP1A1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000754	0.00489	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.0006	0.00389	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.0006	0.00389	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000564	0.00365	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000487	0.00316	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000485	0.00314	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000484	0.00314	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000481	0.00312	CbGpPWpGaD
Riluzole—CYP1A1—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.000469	0.00304	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000462	0.00299	CbGpPWpGaD
Riluzole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.000459	0.00297	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000341	0.00221	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000319	0.00207	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000319	0.00207	CbGpPWpGaD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.000316	0.00205	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000314	0.00203	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000313	0.00203	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000291	0.00189	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000255	0.00165	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000243	0.00157	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000216	0.0014	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000216	0.0014	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000212	0.00138	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000199	0.00129	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000197	0.00128	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000193	0.00125	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000192	0.00124	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000172	0.00112	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000164	0.00106	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000138	0.000892	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000138	0.000892	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000135	0.000877	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000131	0.000847	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00013	0.000841	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000126	0.000816	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000126	0.000815	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00011	0.000713	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000105	0.000679	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	8.33e-05	0.00054	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	8.28e-05	0.000537	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	8.27e-05	0.000536	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	8.02e-05	0.00052	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—EP300—attention deficit hyperactivity disorder	5.6e-05	0.000363	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	3.57e-05	0.000232	CbGpPWpGaD
